Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

BioPlus Acquisition Corp. - Class A Ordinary Shares (NQ:BIOS)

N/A UNCHANGED
Last Price Updated: 3:46 PM EDT, Oct 6, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BioPlus Acquisition Corp. - Class A Ordinary Shares

Avertix and BIOS Acquisition Corporation Mutually Agree to Terminate Proposed Business Combination
From Avertix Medical Inc.
Via GlobeNewswire
BioPlus Acquisition Corp. Announces Termination of Business Combination Agreement with Avertix Medical, Inc. and its Intention to Liquidate
From BioPlus Acquisition Corp.
Via GlobeNewswire
Heart & Rhythm Institute of Trinity and Avertix Announce Partnership to Improve Cardiac Care and Patient Monitoring
From Avertix Medical Inc.
Via GlobeNewswire
Renown Cardiologist and Professor Ian T. Meredith, MD to Join Avertix Medical’s Board of Directors
From Avertix Medical Inc.
Via GlobeNewswire
Avertix’s Guardian™ System, First and Only FDA-Approved Implantable Heart Attack Detection and Warning System, Now Available at AdventHealth Orlando
AdventHealth Orlando performs their first implant of Guardian™ System, revolutionizing cardiac care in Central Florida 
From Avertix Medical Inc.
Via GlobeNewswire
Avertix, Maker of First and Only FDA-Approved Implantable Heart Attack Warning System, to Become Publicly Traded via Merger with BIOS Acquisition Corporation
From Avertix Medical Inc.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.